Recent Posts
- Groundbreaking Intravenous Gene Therapy Offers New Hope for Metachromatic Leukodystrophy Patients
- Astellas’ Friedreich’s ataxia gene therapy cleared for clinical study after earlier version stumbled
- Autolomous and BioCentriq Partner to Speed Up Cell Therapy Delivery
- Study reviews the role of a ribonucleic acid ‘MALAT1’ in hematological malignancies
- FDA’s biologics chief Peter Marks previews accelerated approval guidance
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
chylomicronemia syndrome
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
Drug Development
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
hepatitis research
HIV
immunotherapy
liver cancer
mRAN
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
SMA Treatment
thyroid
zolgensma